| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
EDITORIAL FOCUS
1Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106; 3Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110; and 2Department of Molecular Biology, Genzyme Corporation, Framingham, Massachusetts 01701
Submitted 15 July 2003 ; accepted in final form 20 September 2003
In cystic fibrosis (CF) there is an excessive inflammatory response to lung infections with Pseudomonas aeruginosa, which causes significant morbidity and mortality. Mice deficient in the cystic fibrosis conductance transmembrane regulator homolog (Cftr) have exaggerated production of proinflammatory cytokines in epithelial lining fluid and increased mortality in response to chronic bronchopulmonary infection with mucoid P. aeruginosa, compared with infected wild-type littermates. Whether delivery of CFTR to CF airways by an adenoviral vector (Ad2/CFTR-16) decreases cytokine production and mortality in response to chronic bronchopulmonary infection with mucoid P. aeruginosa was tested. CF mice [stock Cftrtm1Unc-TgN(FABPCFTR)#Jaw] were anesthetized with isoflurane and inoculated intranasally with either Ad2/CFTR-16, diluent (sucrose), or empty vector (Ad2/EV). Two weeks later, mice were anesthetized with 2.5% Avertin and inoculated transtracheally with P. aeruginosa-laden agarose beads (PA M57–15). The cumulative 10-day survival of mice pretreated with Ad2/CFTR-16 was significantly higher compared with mice pretreated with sucrose but not significantly higher than mice pretreated with Ad2/EV. After adjusting for differences in experiment, we found weight loss at 3 days for mice treated with Ad2/CFTR-16 to be significantly less than for the sucrose- or Ad2/EV-treated groups. However, cytokine responses were similar in all groups 3 days after infection. In conclusion, the observed survival advantage of adenoviral delivery of CFTR to the CF lung may be due either to CFTR expression or possibly to proinflammatory effects of the adenoviral vector, or both.
animal model; gene therapy; inflammation; lung infection; host response; cystic fibrosis; cystic fibrosis transmembrane conductance regulator
This article has been cited by other articles:
|
|
 |
|
  I Kukavica-Ibrulj and R C Levesque Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies Lab Anim, October 1, 2008; 42(4): 389 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. van Heeckeren, M. D. Schluchter, W. Xue, and P. B. Davis Response to Acute Lung Infection with Mucoid Pseudomonas aeruginosa in Cystic Fibrosis Mice Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 288 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Liu, Z. Yan, M. Luo, and J. F. Engelhardt Species-Specific Differences in Mouse and Human Airway Epithelial Biology of Recombinant Adeno-Associated Virus Transduction Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 56 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. van Heeckeren, M. D. Schluchter, M. L. Drumm, and P. B. Davis Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L944 - L952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Schwiebert Cystic fibrosis, gene therapy, and lung inflammation: for better or worse? Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L715 - L716. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
